Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09TAB
|
|||
| Former ID |
DIB008584
|
|||
| Drug Name |
Pexidartinib
|
|||
| Synonyms |
PLX-3397
Click to Show/Hide
|
|||
| Indication | Tenosynovial giant cell tumour [ICD-11: 2F7B; ICD-10: D48.0] | Approved | [1] | |
| Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 3 | [2] | ||
| Pigmented villonodular synovitis [ICD-11: FA27.1; ICD-10: M12.2] | Phase 3 | [3] | ||
| Neurofibromatosis type 1 [ICD-11: LD2D.10; ICD-10: Q85.0] | Phase 1/2 | [4] | ||
| Company |
Plexxikon Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H15ClF3N5
|
|||
| Canonical SMILES |
C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F
|
|||
| InChI |
1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)
|
|||
| InChIKey |
JGWRKYUXBBNENE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1029044-16-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:145373
|
|||
| ADReCS Drug ID | BADD_D02515 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019 | |||
| REF 2 | ClinicalTrials.gov (NCT02371369) PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS). U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.